SU4984 |
Katalog-Nr.GC61957 |
SU4984 ist ein Proteintyrosinkinase-Inhibitor mit einem IC50-Wert von 10-20 μM fÜr den Fibroblasten-Wachstumsfaktor-Rezeptor 1 (FGFR1). SU4984 hemmt auch den Thrombozyten-Wachstumsfaktor-Rezeptor und den Insulinrezeptor. SU4984 kann fÜr die Krebsforschung verwendet werden.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 186610-89-9
Sample solution is provided at 25 µL, 10mM.
SU4984 is a protein tyrosine kinase inhibitor, with an IC50 of 10-20 µM for fibroblast growth factor receptor 1 (FGFR1). SU4984 is also inhibits platelet-derived growth factor receptor, and insulin receptor. SU4984 can be used for the research of cancer[1][2][3].
SU4984 (5-100 µM; 5 min) inhibits the kinase activity of FGFR1K with an IC50 of 10-20 µM in the presence of 1 mM adenosine triphosphate (ATP)[1].SU4984 (10-90 µM; 5 min) inhibits the autophosphorylation of FGFR1 induced by aFGF in NIH 3T3 cells, with an IC50 of 20-40 µM[1].SU4984 (5 µM) substantially reduces tyrosine phosphorylation of the wild-type receptor and reduces 50% phosphorylation of constitutive C2 KIT[2].SU4984 (1-10 µM; 6 days) kills the C2 and P815 cells[2].
References:
[1]. Mohammadi M, et, al. Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors. Science. 1997 May 9;276(5314):955-60.
[2]. Ma Y, et, al. Indolinone derivatives inhibit constitutively activated KIT mutants and kill neoplastic mast cells. J Invest Dermatol. 2000 Feb;114(2):392-4.
Average Rating: 5
(Based on Reviews and 27 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *